DrugLogic, Inc. Announces Roll Out Of Qscan Version 3
10/19/2005 5:10:43 PM
DrugLogic(TM), Inc. is pleased to announce Qscan(TM) Version 3 to be rolled out later this summer for all current Qscan(TM) implementations; Qscan(TM) PRO (proprietary data application) as well as Qscan(TM) FDA (FOI, AERS data) and Qscan(TM) World (WHO-UMC data). Qscan(TM) is DrugLogic's flagship product used to monitor and analyze both drug company proprietary adverse event data and publicly available data. New features of version 3 will be demonstrated at the International Society for Pharmacoepidemiology (ISPE) conference in Bordeaux 22-25 August.
comments powered by